Molecular Partners Ag (MOLN) Receivables - Other (2020 - 2025)

Molecular Partners Ag (MOLN) has reported Receivables - Other for 6 consecutive years, with $101344.8 the latest figure, recorded in Q4 2025.

• Quarterly Receivables - Other rose 15.3% year-over-year to $101344.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $101344.8 (up 15.3% YoY) and the FY2025 annual result came in at $101344.8, up 15.3% from the prior year.
• Receivables - Other grew to $101344.8 in Q4 2025 per MOLN's latest filing, from $87897.2 in the prior quarter.
• Over the last five years, Receivables - Other for MOLN reached as high as $158337.3 in Q4 2021 and fell as low as $74405.4 in Q4 2023.
• A 5-year average of $99967.3 and a median of $87897.2 in 2024 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2021 — Receivables - Other tumbled 87.02% — and 2024, when it increased 18.13%.
• Year by year, Receivables - Other stood at $158337.3 in 2021, then plunged by 50.83% to $77851.6 in 2022, then retreated by 4.43% to $74405.4 in 2023, then advanced by 18.13% to $87897.2 in 2024, then gained by 15.3% to $101344.8 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $101344.8, $87897.2, and $74405.4 for Q4 2025, Q4 2024, and Q4 2023 respectively.